Form 4: Oscar Health Executive Ranmali Bopitiya Reports Stock Transactions
SEC Form 4
Ranmali Bopitiya, EVP & Chief Legal Officer of Oscar Health, reports the vesting and sale of Class A Common Stock to cover tax obligations.
Summary
- On March 1, 2024, Ranmali Bopitiya, EVP & Chief Legal Officer of Oscar Health, Inc., acquired 20,425 shares of Class A Common Stock through the vesting of restricted stock units.
- On the same day, an additional 16,447 shares were acquired through the vesting of further restricted stock units.
- On March 4, 2024, Bopitiya sold 11,426 shares of Class A Common Stock at a weighted average price of $15.88 per share.
- The sale was executed to satisfy tax withholding obligations related to the vesting of previously granted equity awards, pursuant to a Rule 10b5-1 trading plan established before February 27, 2023.
- Following these transactions, Bopitiya directly owns 113,264 shares of Class A Common Stock and holds 163,399 and 197,369 restricted stock units from the grants on June 1, 2022 and June 1, 2023 respectively.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The document simply reports stock transactions by an executive, which is a routine occurrence. There's no indication of positive or negative implications for the company's performance.
Positives
- The transactions are part of a pre-planned strategy (Rule 10b5-1) to manage tax obligations, indicating proactive financial planning.
Future Outlook
The document does not contain any specific forward-looking statements regarding the company's future performance or outlook.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It provides transparency regarding insider transactions but doesn't necessarily reflect broader industry trends.
Comparison to Industry Standards
- Executive stock sales to cover tax obligations upon vesting of equity awards are a common practice across publicly traded companies.
- Rule 10b5-1 trading plans are frequently used by executives to avoid accusations of insider trading, aligning with standard corporate governance practices.
- Comparable companies in the health insurance or technology sectors, such as UnitedHealth Group (UNH) or Teladoc Health (TDOC), also regularly disclose similar Form 4 filings for their executives.
Stakeholder Impact
- The stock sale could have a minor, temporary impact on the stock price, but the overall impact on stakeholders is likely minimal given the relatively small volume of shares sold.
Key Dates
| Date | Description |
|---|---|
| 2022-01-14 | Date of Power of Attorney execution. |
| 2022-06-01 | Vesting start date for 20,425 restricted stock units. |
| 2023-02-27 | Date before which the Rule 10b5-1 instruction letter was entered into. |
| 2023-06-01 | Vesting start date for 16,447 restricted stock units. |
| 2024-03-01 | Vesting of 20,425 and 16,447 shares of Class A Common Stock. |
| 2024-03-04 | Sale of 11,426 shares of Class A Common Stock. |
| 2024-03-05 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.